In May 2026, an international consensus process renamed "polycystic ovary syndrome" to "polyendocrine metabolic ovary syndrome," PMOS for short. The reason: the old name centred on cysts, which neither occur in every affected woman nor describe what matters most. The diagnostic criteria have stayed the same through the renaming.
Need help? 💬
If you have any questions, feel free to contact us:
💬 Chatbot – Available on our website
📧 Email: [email protected]
